medigraphic.com
Órgano Oficial de el Colegio Mexicano de Urología

2007, Number 2

<< Back Next >>

Bol Col Mex Urol 2007; 22 (2)

Estudio comparativo entre el resultado de la escala de Gleason en la biopsia transrectal guiada por ultrasonido y el resultado de escala de Gleason en la prostatectomía radical de los pacientes con cáncer de próstata

Sánchez MLC, Padilla RA

Language: Spanish
References: 71
Page: 77-82
PDF size: 501.36 Kb.


ABSTRACT

Introduction: Tumor stadification by Gleason grade is important for therapeutic decision in patients with prostate cancer. Objective: To compare Gleason grade between transrectal biopsy and Gleason grade radical prostatectomy. Methods: Observational retrospective transversal and comparative study in male patients of Urology Department in “Hospital de Especialidades del Centro Médico Nacional La Raza” from September 2002 to January 2006 evaluating prostatic specific antigen, prostate volume, transrectal biopsy and radical prostatectomy Gleason´s grade, extraprostatic extension with Sperman’s correlation and χ2. Results: Transrectal biopsy: Gleason’s 5: 1 patient, Gleason’s 6: 28, Gleason’s 7 (3 + 4): 2, Gleason’s 7 (4+3): 8 and Gleason’s 8: 1. Radical prostatectomy: Gleason’s 6: 14, G7 (3+4): 6, G7 (4+3): 11, G8: 5, G9 (4+5): 2, G9 (5+4): 1 and G10: 1. The results were independent with the statistical analysis. Conclusions: There were no statistical relationship between the studied values because the sub or supradiagnostic of the comparative study. There were an independent correlation.


REFERENCES

  1. Walsh PC. Campbell´s Urology. 8th. Ed. Saunders; 2002, p. 3001-226.

  2. Catalona WJ, Loeb S, Misop H. Viewpoint: expanding prostate cancer screening. Ann Intern Med 2006; 144: 441-3.

  3. Grossklaus DJ, et al. Percent of cancer in the biopsy set predicts pathological findings after prostatectomy. J Urol 2002; 167: 2032-6.

  4. Master VA, Chi T, Simko JP, Weinberg V, Carroll PR. The independent impact of extended pattern biopsy on prostate cancer stage migration. J Urol 2005; 174: 1789-893.

  5. Lattouf JB, Saad F. Gleason score on biopsy: is it reliable for predicting the final grade on pathology. BJU International 2002; 90: 694-9.

  6. Thompson KE, Hernández J, Canby-Hagino ED, Troyer D, Thompson IM. Prognostic features in men who died of prostate cancer. J Urol 2005; 174: 553-6.

  7. San Francisco IF, DeWolf WC, Rosen S, Upton M, Olumi AF. Extended prostate needle biopsy improves concordance of gleason grading between prostate needle biopsy and radical prostatectomy. J Urol 2003; 169: 136-40.

  8. King CR, Patel DA, Terris MK. Prostate biopsy volume indices do not predict for significant Gleason upgrading. Am J Clin Oncol 2005; 28: 125-9.

  9. Winkler MH, et al. The total percentage of biopsy cores with cancer improves the prediction of pathological stage after radical prostatectomy. BJU International 2004; 94: 812-5.

  10. 10.Steinberg D, Sauvageot J, Piantadosi S, Epstein JI. Correlation of prostate needle biopsy and radical prostatectomy Gleason grade in academic and community settings. Am J Surg Path 1997; 21(5): 566- 76.

  11. 11.Epstein JI, Allsbrook WC, Amin MB, Egevad LL. The 2005 international society of urological pathology (ISUP) consensus conference on gleason grading of prostatic carcinoma. Am J Surg Pathol 2005; 29(9): 1228-42.

  12. 12.Mesut R, et al. The Vienna nomogram: validation of a novel biopsy strategy defining the optimal number of cores based on patient age and total prostate volume. J Urol 2005; 174: 1256-61.

  13. Glick LB. Circumcision from Ancient Judea to Modern America. En: Glick LB (ed.). Circumcision from Ancient Judea to Modern America. Nueva York: Oxford University Press, 2005.

  14. Estébañez ZMJ. Carcinoma del pene. Actas Urol Esp 1987; 11: 451.

  15. Perea J, Rodríguez LJM, Fernández A, Escudero BA. Carcinoma de Pene. Nuestra Experiencia y revisión de la literatura. Actas Urol Esp 1989; 13: 24.

  16. Asociación Andaluza de Urología. Cáncer de pene: Grupo cooperativo de la provincia de Cádiz. Actas Urol Esp 1996; 5: 448.

  17. Griffiths TRI, Mellon JK. Human papillomavirus and urological tumors: I. Basic science and role in penile cancer. BJU International 1999; 84: 5791.

  18. Pietrzak P, Watkin N. Penile cancer. BJU International 2003; 6: 14.

  19. Ritchie AWS, Foster PW, Foeler S. Penile cancer in the UK: presentation and outcome in 1998/99. BJU International 2004; 94: 1248.

  20. Riveros M, Lebron RF. Geographical pathology of cancer of the penis. Cancer 1963; 16: 798.

  21. Kaufman JJ, Sternberg TH. Carcinoma of the penis in a circumcised man. J Urol 1963; 90: 499.

  22. 10.López LJD. Tumores de pene. En: López Laur JD (ed.). Manual de urología moderna. Buenos Aires: Editorial Atlante; 2004, p. 361.

  23. 11.Barroso E, Rendón J, Medina R, Mora T, De la Mora S. Registro Nacional del Cáncer. Rev del INC 1986; 32: 190.

  24. 12.Woolrich DJ. Carcinoma del Pene. En: Woolrich DJ (ed.). Urología e introducción a la sexología. México: Francisco Méndez Cervantes 1984, p. 425.

  25. 13.Demkow T. The treatment of penile carcinoma: Experience in 64 cases. Int Urol & Nephrol 1999; 4: 525.

  26. 14.Hoppman HJ, Fraley EE. Squamous cell carcinoma of the penis. J Urol 1978; 120: 393.

  27. 15.Micali G, Nasca MR, Innocenzi D, Schwartz RA. Invasive penile carcinoma: A review. Dermatol Surg 2004; 30: 311.

  28. 16.Bañón PVJ, Nicolás TJA, Valdevira NP, Server PG, Martínez BE, Gómez GG, et al. Neoplasias malignas del pene. Actas Urol Esp 2000; 8: 652.

  29. 17.Busby JE, Pettaway CA. What’s new in the management of penile cancer? Current Opinion in Urology 2005; 5: 350.

  30. 18.Pellicé VC, Esquius SJ, Parés PME, Ordi MJ. Tumor peneano. Incidencia casual en la práctica de una postectomía. Visión macroscópica. Estudio Microscópico. Actas Urol Esp 2001; 3: 249.

  31. 19.Peyrí E. Exploración de las lesiones cutáneas. En: Peyrí E (ed.). Enfermedades cutáneas del aparato genital masculino. Madrid: Ene Ediciones; 1996, p. 17.

  32. 20.Arango O. Lesiones vasculares de los genitales externos masculinos. En: Peyrí E (ed.). Enfermedades cutáneas del aparato genital masculino. Madrid: Ene Ediciones; 1996, p. 39.

  33. 21.Pratt THR, Heins HC, Latham E, Dennis EJ, Melver FA. The carcinogenic effect of human smegma: an experimental study. Cancer 1956; 9: 671.

  34. 22.Derrick FC Jr, Lynch KM, Kretkowski RC. Epidermoid carcinoma of the penis: computer analysis of 87 cases. J Urol 1973; 110: 303.

  35. 23.Román F, Sanz M, Otero I, Golbano J. Nuestra experiencia en tumores de pene. Reun Reg Asoc Esp Urol 1981; 5: 1.

  36. 24.Schellhammer PF, Grabstald H. Tumores del pene. En: Walsh PC, Gittes RF, Perlmutter AD, Stamey TA (eds.). Urología de Campbell. 5a. Ed. Vol. 2. Buenos Aires: Médica Panamericana; 1988, p. 1708.

  37. 25.Fraley EE, Zhang G, Sazama R, Lange PH. Cancer of the penis. Prognosis and treatment plans. Cancer 1985; 55: 1618.

  38. 26.Castellsague X, Bosch FX, Muñoz N, Meijer CJLM, Shah KV, De Sanjose S, et al. Male Circumcision, Penile Human Papillomavirus Infection, and Cervical Cancer in Female Partners. N Engl J Med 2002; 346: 1105. 27.Ellsworth P, Rous SN. Penile cancer. En: Ellsworth P y Rous SN (eds.). Blackwell’s primary care essentials: urology. EE.UU: Edwards Brothers; 2001, 127.

  39. 28.Malek RS, Goellner JR, Smith TF, Espy MJ, Cupp MR. Human papillomavirus infection and intraepithelial, in situ, and invasive carcinoma of penis. J Urol 1993; 42: 159.

  40. 29.Solsona NE. Tumores malignos del pene. En: Jiménez CJF, Rioja SLA (eds.). Tratado de Urología. Tomo II. Barcelona: JR Proas; 1993, p. 1259.

  41. 30.Presti JC. Tumores genitales. En: Tanagho EA y McAninch JW (eds.). Urología General de Smith. 13a. Ed. México: El Manual Moderno; 2005, p. 377.

  42. 31.Clemente RLM, Maganto PE, García GR, Burgos RFJ, Fernández CS, Crespo ML, et al. Carcinoma verrucoso de pene. Aportación de seis nuevos casos y revisión de aspectos diagnósticos y terapéuticos. Actas Urol Esp 1997; 4: 372.

  43. 32.Lowe D, Mc Kee PH. Verrucous carcinoma of the penis: A clinico-pathological study. Br J Urol 1983; 55: 427.

  44. 33.Ortiz CR, Adriazola SM, Blanco PMA, García CE, Tejeda BE, Romero RF. Lesiones cutáneas de pene. Metástasis de adenocarcinoma de próstata. Aportación de un caso. Actas Urol Esp 1999; 2: 153.

  45. 34.Paulson DF, Pérez CA, Anderson T. Neoplasias genitourinarias. En: De Vita VT, Hellman S, Rosemberg SA (eds.). Principios y práctica de oncología. Barcelona: Salvat; 1984, p. 680.

  46. 35.Maldonado AE, Lorenzo MJL, Vega EJJ, Otero GJM, Wingartz PHF. Cáncer de próstata metastático a pene: Descripción de un caso y revisión de la literatura. Bol Col Mex Urol 2003; 2: 75.

  47. 36.Mijangos RGE, Wingartz PHF, Moreno AJ. Sarcoma de Kaposi en el pene, presentación de un caso y revisión de la bibliografía. Bol Col Mex Urol 1998; 2: 49.

  48. 37.Parés PME, Pérez HS, Cosme JMA. Sarcoma de Kaposi. Informe de un caso. Bol Col Mex Urol 2002; 2: 112.

  49. 38.Sufrin G, Huben R. Benign and malignant lesions of the penis. En: Guillen WJY (ed.). Adult and Pediatric Urology, Chicago: Year Book Medical Publisher, 1991: 1462.

  50. 39.Cruz GNA, Allona AA, Clemente RL, Linares QA, Briones MG, Escudero BA. Linfadenectomía en el carcinoma escamoso de pene: revisión de nuestra serie. Actas Urol Esp 2000; 9: 709.

  51. 40.Crawford ED, Sakti D. Penile, urethral and scrotal cancer. Urol Clin North Am, WB Saunders Company, 1992; 2: 420.

  52. 41.Jackson SM. The treatment of carcinoma of the penis. Br J Surg 1966; 53: 33.

  53. 42.U.I.C.C.: classification of malignant tumors. 3rd edition. International Union Against Cancer. Ginebra, 1978.

  54. 43.Mukamel E, De kernion JB. Disección ganglionar precoz versus tardía versus nula en el carcinoma de pene. Clin Urol Norte Am, Inter-Médica, 1988; 4: 55.

  55. 44.Catalona WJ. Rol of lymphademectomy in carcinoma of the penis. Urol Clin North Am 1980; 7: 785.

  56. 45.Herr HW. Cirugía del carcinoma de pene y la uretra. En: Walsh PC, Retik AB, Stamey TA, Vaughan ED (eds.). Campbell urología. 6a Ed. Vol. 3. Buenos Aires: Médica Panamericana; 1994, p. 3020.

  57. 46.Swan MC, Furniss D, Cassell OCS. Surgical management of metastatic inguinal lymphadenopathy. BMJ 2004; 329: 1272.

  58. 47.Saisorn I, Lawrentschuk N, Leewansangtong S, Bolton DM. Fine-needle aspiration cytology predicts inguinal lymph node metastasis without antibiotic pretreatment in penile carcinoma. BJU International 2006; 6: 1225.

  59. 48.Santacruz RAM, Martínez SR, Muñoz RJA. Tratamiento quirúrgico del carcinoma epidermoide de pene. Bol Col Mex Urol 1980; 2: 93.

  60. 49.Bissada NK, Morcos RR, El-Senoussi M. Post-circumcision carcinoma of the penis. Clinical aspects. J Urol 1986; 135: 283.

  61. 50.Pietrzak P, Corbishley C, Watkin N. Organ-sparing surgery for invasive penile cancer: early follow-up data. BJU International 2004; 94: 1253.

  62. 51.Donnelan SM, Webb DR. Managment of invasive penile cancer by synchronous penile lengthening and radical tumor excision to avoid perineal urethrostomy. Aust N Z J Surg 1998; 68: 369.

  63. 52.Cabañas RM. An approach for the treatment of penile carcinoma. Cancer 1977; 41: 880.

  64. 53.Fowler JE Jr. Sentinel lymph node biopsy for staging penile cancer. Urology 1984; 23: 352.

  65. 54.Singh R, James ND, Watkin NA. Future development of penile cancer services in the UK. BJU Internacional 2004; 4: 967.

  66. 55.Puras BA, Rivera HJ. Tratamiento del cáncer de pene y sus recidivas. En: Jiménez CJF y Vera DCD (eds.). Diagnóstico y tratamiento de la recidiva en los tumores urológicos. España: Aula Médica, S.A., 1996, p. 211.

  67. 56.Lieskovsky G. Linfadenectomía pélvica. En: Glenn JF y Boyce WH (eds.). Cirugía urológica. España, Salvat; 1987, p. 951.

  68. 57.Ricós JV, Casanova J, Iborra J. El tratamiento locorregional del carcinoma de pene. Arch Esp Urol 1991; 44: 677.

  69. 58.Theodore C. Do patients with penile carcinoma benefit from immediate resection of clinically occult lymph node metastases? Nat Clin Prac Urol 2005; 2: 324.

  70. 59.De Kernion JB, Persky K. Neoplastic lesions of the penis. En: Skinner, De Kernion (eds.). Genitourinary cancer. Filadelfia: W.B. Saunders Company; 1978, p. 494.

  71. 60.Hussein AM, Benedetto P, Sridhar KS. Chemotherapy with cisplatin and 5-fluorouracil for penile and urethral squamous cell carcinomas. Cancer 1990; 65: 433.




2020     |     www.medigraphic.com